V, G., D, P., G, E., E, S., M, A., CKW, D., . . . P, I. (2022). Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial. Cancers, 14(21), . https://doi.org/10.3390/cancers14215234
Chicago Style (17th ed.) CitationV, Grünwald, et al. "Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial." Cancers 14, no. 21 (2022). https://doi.org/10.3390/cancers14215234.
MLA (9th ed.) CitationV, Grünwald, et al. "Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial." Cancers, vol. 14, no. 21, 2022, https://doi.org/10.3390/cancers14215234.
Warning: These citations may not always be 100% accurate.